Showing results (1-10 of 62) with videos related to
Sort By:
Pageof 7
Renal Failure|December 13, 2006
End-stage renal failure and national resources: the Brazilian experienceRoberto Zatz, João Egídio RomãoJournal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|August 20, 2002
Mechanisms of progressive renal disease: role of angiotensin II, cyclooxygenase products and nitric oxideRoberto Zatz, Clarice Kazue FujiharaPhysiology (Bethesda, Md.)|October 24, 2023
Endothelium-Derived Dopamine and 6-Nitrodopamine in the Cardiovascular SystemRoberto Zatz, Gilberto De NucciKidney International. Supplement|July 15, 2005
End-stage renal disease in Brazil: epidemiology, prevention, and treatmentMarília Bahiense Oliveira, João Egídio Romão, Roberto ZatzJournal of Cardiovascular Pharmacology|January 16, 2015
A nonpeptide angiotensin II type 2 receptor agonist prevents renal inflammation in early diabetesLuis C Matavelli, Roberto Zatz, Helmy M SiragyKidney International. Supplement|July 17, 2003
Nephrology in Latin America, with special emphasis on BrazilRoberto Zatz, J E Romão, I L NoronhaAmerican Journal of Physiology. Renal Physiology|November 12, 2002
Experimental and clinical rationale for use of MMF in nontransplant progressive nephropathiesRoberto Zatz, Irene Lourdes Noronha, Clarice Kazue FujiharaAmerican Journal of Physiology. Renal Physiology|March 9, 2007
Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation modelClarice Kazue Fujihara, Denise M A C Malheiros, Roberto ZatzKidney International|April 21, 2005
An extremely high dose of losartan affords superior renoprotection in the remnant modelClarice Kazue Fujihara, Mariliza Velho, Denise Maria Avancini Costa Malheiros, et al.American Journal of Nephrology|May 28, 2016
Furosemide Increases the Risk of Hyperparathyroidism in Chronic Kidney DiseaseRaquel F V Vasco, Rosa M A Moyses, Roberto Zatz, et al.Pageof 7